


Find new investment opportunities based on Market Sentiment Indicator. Manage watchlist risk with leading indicator of volatility See what influential analysts and investors are saying about stocks in My Watchlist
Most Trending
+3.14%
+0.19%
+1.56%
CRL
Charles River Labora
$171.50
Strengths

Upgraded on attractively valued

Earnings are forecast to grow

Outperform the market

Expands stock buyback program
Chart
$170.72 (+0.46%)
$158.48 (+8.22%)
$145.29 (+18.04%)
$199.06 (-13.85%)
CRL has Moderate risk level based on volatility, sector strength, volume, investor confidence, and outlook.
Click here to check what is your level of risk
Risks Indicators

Beta greater than 1.0

CRL overall standing based on key factors, offering insights into analysts perspectives and market expectations.
Hover over the category for more information
Earnings
Earnings

Above analyst estimates

Revenue declined YoY

Reported a strong earnings
Rating
Rating

Upgraded on attractively valued
Momentum
Momentum

Price value has negative momentum
Activity
Activity

Expands stock buyback program
Future
Future

Earnings are forecast to grow

Outperform the market
![]()
CRL Analysts opinion is positive and also has improved from the past 3 months
Analysts perspectives on the stock desirability, trend direction, and growth potential.
CRL Street Sentiment is bullish and have positive views on the near-term outlook
Average key support and resistance price levels.
Login to displayWhat is CRL current stock price?
What are CRL stock strengths?
What risks are associated with CRL stock?
When is CRL next earnings report?
What is CRL market cap and volume?
What is CRL's current Stock IQ?
Should I buy CRL stock right now?
Is CRL a Strong Buy right now?
What does a 'Strong Buy' rating mean for CRL?
What does a 'Strong Sell' rating mean for CRL?
What factors influence CRL's Stock IQ?
Join over 10,000+ subscribers who value exclusive insights. Stay ahead in the stock market! Enter your email for daily alerts
Stay ahead of the market
Market trends
Investment tips
Market analysis service
Future potential
Informed investment decisions
Investment analysis
IInvestment strategies
In-depth stock analysis
Performance analysis
Stock market insights
Financial trends analysis
Most Trending
+3.14%
+0.19%
+1.56%
CRL
Charles River Labora
Current Price
$171.50
Stock Insights
Strengths

Upgraded on attractively valued

Earnings are forecast to grow

Outperform the market

Expands stock buyback program

Chart
$170.72 (+0.46%)
$158.48 (+8.22%)
$145.29 (+18.04%)
$199.06 (-13.85%)
CRL Analysts Opinion
CRL Overall standing by considering key factors, reflecting analysts perspectives and market expectations.
Hover over the category for more information
Earnings
Earnings

Above analyst estimates

Revenue declined YoY

Reported a strong earnings
Rating
Rating

Upgraded on attractively valued
Momentum
Momentum

Price value has negative momentum
Activity
Activity

Expands stock buyback program
Future
Future

Earnings are forecast to grow

Outperform the market
![]()
CRL Analysts opinion is positive and also has improved from the past 3 months
Analysts perspectives on the stock desirability, trend direction, and growth potential.
CRL Street Sentiment is bullish and have positive views on the near-term outlook
CRL has Moderate risk level based on volatility, sector strength, volume, investor confidence, and outlook.
Click here to check what is your level of risk
Risks Indicators

Beta greater than 1.0

Average key support and resistance price levels.
CRL Latest Analysis
Morgan Stanley Maintains Charles River Laboratories International (CRL) Equal-Weight Recommendation. Fintel reports that on November 11 2025 Morgan Stanley maintained coverage of Charles River Laboratories International (NYSE:CRL) with a Equal-Weight recommendation. Analyst Price Forecast Suggests 11.06% Upside
Today
Charles River Beat Expectations But Why Is The Stock Falling?. CRL) stock is trading lower on Wednesday after the company released . It also provided an update on the company’.s strategic review.CRL is feeling the pressure from bearish momentum. The life science tools company reported quarterly revenue of $1.01billion a 0.5% decrease year-over-year beating the consensus estimate .The impact of foreign currency translation increased reported revenue by 1.3% and the divestiture of a small Saf
Wed Nov 5, 2025
Charles River: Mixed Q3 As Strategic Review Disappoints.
Wed Nov 5, 2025
Charles River Laboratories outlines $1B buyback targets $70M cost savings and divestitures amid strategic review.
Wed Nov 5, 2025
CRLs Q3 Earnings Top Estimates Revenues Decline Y/Y Stock Falls. Charles River beats Q3 profit and revenue forecasts but posts year-over-year declines and narrows its 2025 outlook.
Wed Nov 5, 2025
Charles River Laboratories (CRL) Q3 Earnings and Revenues Surpass Estimates. Charles River (CRL) delivered earnings and revenue surprises of 4.74% and 2.06% respectively for the quarter ended September 2025. Do the numbers hold clues to what lies ahead for the stock?
Wed Nov 5, 2025
Charles River Laboratories International Inc. Q3 Profit Decreases But Beats Estimates . (RTTNews) - Charles River Laboratories International Inc. (CRL) reported a profit for third quarter that Decreased from last year but beat the Street estimates.
Wed Nov 5, 2025
Charles River Laboratories Non-GAAP EPS of $2.43 beats by $0.09 revenue of $1B beats by $9.21M.
Wed Nov 5, 2025
Heres How Charles River Stock Is Placed Ahead of Q3 Earnings. CRL heads into Q3 earnings with steady RMS growth but faces DSA headwinds from tight biotech budgets.
Fri Oct 24, 2025
FIND US ON
Unlock the knowledge that 10,000+ subscribers already cherish. Join for exclusive insights and stay ahead in the stock game! Enter your email to receive daily alerts
In-depth stock analysis
Informed investment decisions
Stock market insights
Stock trading tips
Disclaimer:
Past performance, whether from actual results or historical strategy tests, does not guarantee future success. The displayed outcomes are based on strategies not previously available to investors and do not depict the returns achieved by any specific investor.
The Readiness Indicators, Sentiment Indicators, and overall score are derived from a model retrospectively applied using historical data. This model relies on assumptions inherent to it, which may or may not be verifiable and carry potential risks, including losses.
Engaging in active trading may not be suitable for individuals with limited resources, minimal investment or trading experience, or a low-risk tolerance. Proceed with caution as your capital is exposed to risks.
Please note that no offer or solicitation to buy or sell securities, securities derivatives of future products of any kind, or any type of trading or invesment advise, recommendation or strategy, is made, given or endorsed by StocksRunner including any of their affiliates ("TS").
This information is provided for illustrative purposes only. You should not rely on any advice and/or information contained in this website and before making any investment decision. we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice.